Publicação

Roux-en-Y gastric bypass vs sleeve gastrectomy in super obesity: a systematic review and meta-analysis

Ver documento

Detalhes bibliográficos
Resumo:Laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic sleeve gastrectomy (LSG) are safe procedures that may present sub-optimal results in superobesity (SO). A meta-analysis was performed aiming to summarize the available evidence on weight loss (primary outcome) and comorbidities resolution of LRYGB and LSG in patients with SO (BMI ≥ 50 kg/m2). From the 16 included studies, 7 integrated the meta-analysis. LRYGB showed a significantly higher weight loss at 6 to 12-months, but not after 24 months and a higher dyslipidemia resolution at 12 months. When compared with LSG, LRYGB achieved better weight loss after 6 and 12 months and higher dyslipidemia resolution after 1 year. There were no significant differences for resolution of the other co-morbidities studied.
Autores principais:Gomes-Rocha, Sofia Raquel
Outros Autores:Costa-Pinho, André Manuel; Pais-Neto, Carolina Coelho; de Araújo Pereira, André; Nogueiro, Jorge Pedro Martins; Carneiro, Silvestre Porfírio Ramos; Santos-Sousa, Hugo Miguel Teixeira Ferraz; Lima-da-Costa, Eduardo Jorge; Bouça-Machado, Raquel; Preto, John Rodrigues
Assunto:Bariatric surgery Comorbidity resolution LRYGB LSG Laparoscopic Roux-en-Y gastric bypass Laparoscopic sleeve gastrectomy Meta-analysis Super obesity Weight loss
Ano:2021
País:Portugal
Tipo de documento:artigo
Tipo de acesso:acesso restrito
Instituição associada:Universidade de Lisboa
Idioma:inglês
Origem:Repositório da Universidade de Lisboa
Descrição
Resumo:Laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic sleeve gastrectomy (LSG) are safe procedures that may present sub-optimal results in superobesity (SO). A meta-analysis was performed aiming to summarize the available evidence on weight loss (primary outcome) and comorbidities resolution of LRYGB and LSG in patients with SO (BMI ≥ 50 kg/m2). From the 16 included studies, 7 integrated the meta-analysis. LRYGB showed a significantly higher weight loss at 6 to 12-months, but not after 24 months and a higher dyslipidemia resolution at 12 months. When compared with LSG, LRYGB achieved better weight loss after 6 and 12 months and higher dyslipidemia resolution after 1 year. There were no significant differences for resolution of the other co-morbidities studied.